Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction have?
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction has 2,742 citations in the OpenAlex counts ScholarIQ stores.
When was Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction published?
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction has 2022 year in the ScholarIQ index.
What is the open-access status of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction?
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction has bronze oa status in the ScholarIQ index.
What is the DOI of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction?
The DOI for Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction is on the source record.
What is the PMID of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction?
The PMID for Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction is on the source record.
What is the OpenAlex record for Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction?
The OpenAlex for Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction is on the source record.